NIDDK Central Repository - Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis.

An official website of the United States government

NIDDK Central Repository

Publication Information

DOI

10.1016/j.ahj.2011.05.004

PubMed ID

21835294

Public Release Type

Journal

Publication Year

2011

Affiliation

Division of Nephrology, Stanford University School of Medicine, Palo Alto, CA 94304, USA. tichang@stanford.edu

Authors

Brunelli SM, Chang TI, Chertow GM, Cheung AK, Shilane D, Winkelmayer WC

Studies

HEMO

Citation

Chang TI, Shilane D, Brunelli SM, Cheung AK, Chertow GM, Winkelmayer WC. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J 2011 Aug;162(2):324-30. Epub 2011 Jul 18.

Abstract

Persons with end-stage renal disease (ESRD) on hemodialysis carry an exceptionally high burden of cardiovascular disease. Angiotensin-converting enzyme inhibitors (ACEIs) are recommended for patients on dialysis, but there are few data regarding their effectiveness in ESRD.